Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Hurwitz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of School Psychology|March 10, 2015
Size and consistency of problem-solving consultation outcomes: an empirical analysisJason T Hurwitz, Thomas R Kratochwill, Ronald C Serlin
Expert Review of Pharmacoeconomics & Outcomes Research|October 26, 2022
Cost of illness of stage IV non-small cell lung cancer (NSCLC) positive for programmed cell death ligand 1 (PD-L1) in the USJoshua E Kessler, Kwon N Park, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?Jason T Hurwitz, Mary Brown, Jennifer S Graff, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?Jason T Hurwitz, Mary Brown, Jennifer S Graff, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?Daniel C Malone, Mary Brown, Jason T Hurwitz, et al.
Oncology and Therapy|May 13, 2022
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)Jason T Hurwitz, Shannon Vaffis, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes CareJason T Hurwitz, Amy J Grizzle, Jill Augustine, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipientsJason T Hurwitz, Amy J Grizzle, Carmelina S Tyler, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 27, 2019
Real-World Evidence from the Integrative Medicine Primary Care Trial (IMPACT): Assessing Patient-Reported Outcomes at Baseline and 12-Month Follow-UpRobert L Crocker, Jason T Hurwitz, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectivesAinhoa Gomez Lumbreras, Jason T Hurwitz, Xi Liang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of School Psychology|March 10, 2015
Size and consistency of problem-solving consultation outcomes: an empirical analysisJason T Hurwitz, Thomas R Kratochwill, Ronald C Serlin
Expert Review of Pharmacoeconomics & Outcomes Research|October 26, 2022
Cost of illness of stage IV non-small cell lung cancer (NSCLC) positive for programmed cell death ligand 1 (PD-L1) in the USJoshua E Kessler, Kwon N Park, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|November 30, 2020
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?Jason T Hurwitz, Mary Brown, Jennifer S Graff, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?Jason T Hurwitz, Mary Brown, Jennifer S Graff, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?Daniel C Malone, Mary Brown, Jason T Hurwitz, et al.
Oncology and Therapy|May 13, 2022
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)Jason T Hurwitz, Shannon Vaffis, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes CareJason T Hurwitz, Amy J Grizzle, Jill Augustine, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipientsJason T Hurwitz, Amy J Grizzle, Carmelina S Tyler, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 27, 2019
Real-World Evidence from the Integrative Medicine Primary Care Trial (IMPACT): Assessing Patient-Reported Outcomes at Baseline and 12-Month Follow-UpRobert L Crocker, Jason T Hurwitz, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectivesAinhoa Gomez Lumbreras, Jason T Hurwitz, Xi Liang, et al.
Pageof 2